"Concentrated Exposure Treatment" (cET) for for Obsessive Compulsive Disorder

February 10, 2021 updated by: Haukeland University Hospital

Concentrated Exposure Treatment (cET) for Obsessive Compulsive Disorder (OCD). A Randomized Controlled Trial (RCT)

Obsessive Compulsive Disorder (OCD) often becomes chronic if not treated. Exposure and response prevention (ERP) is recommended psychological treatment. The OCD-team at Haukeland University hospital has developed a concentrated 4-day treatment format which has been evaluated as part of standard care. Next step in the methodological development is to conduct a randomized controlled trial where the 4-day format is compared to self-help and waiting list. The study will be conducted at Solvang DPS, Sørlandet Hospital. Participants (16 in each group) are ordinary patients (>18 yrs) entitled to care in the specialist health care.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

48

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

OCD-patients referred to the OCD-team at Sørlandet Sykehus, Solvang DPS will be included.

Inclusion criteria

  • Outpatients
  • ≥ 18 years of age
  • Fulfilling diagnostic criteria of OCD according to the DSM-5
  • Y-BOCS ≥ 16
  • Fluent in Norwegian
  • Signed informed consent

Exclusion Criteria:

  • OCD symptoms primarily associated with hoarding
  • Ongoing substance abuse/dependence
  • Bipolar disorder or psychosis
  • Ongoing suicidal ideation
  • Mental Retardation, based on previous medical history
  • If using antidepressants:

    • Not on stable dosage 4 weeks before the intervention
    • Unwilling to remain on stable dosage during the four intervention days
  • Unwilling to refrain from anxiety reducing substances, such as anxiolytics (e.g. benzodiazepines) and alcohol during the two days of exposure.
  • Patients living > 1.5 hour drive by car/ train from the treatment location.
  • Patients with a BMI-index considered too low for participation in psychological treatment
  • Patients with a full course of prior CBT for OCD.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Wait list
Experimental: Concentrated Exposure Treatment (cET)
Please refer to:Havnen, A., Hansen, B., Öst, L.-G. & Kvale, G. Concentrated ERP delivered in a group setting: An effectiveness study. Journal of Obsessive Compulsive and Related Disorders 3, 319-324 (2014)
Psychological cognitive behavioral treatment
Active Comparator: Self-help

The self-help condition (SH):

Foa, E.B. & Kozak, M.J. Mastery of obsessive-compulsive disorder: Client workbook, (Graywind Publications, New York, 1997).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Y-BOCS from pre cET-treatment to post treatment/ waiting list/ self-help
Time Frame: Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
Y-BOCS changes will for all conditions be calculated by two approaches which will be compared.
Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
Changes i OCD diagnostic status (DSM-5) as measured by SCID
Time Frame: Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Well-being
Time Frame: Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
The Warwick-Edinburgh Mental Well-being Scale (WEMWBS) will be administered to assess mental well-being. This scale has 14 items covering different aspects of mental health related to mental well-being.
Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
Work and social adjustment
Time Frame: Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
The Work and Social Adjustment Scale (W & SAS) is a short questionnaire measuring work and social adjustment.
Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
Generalized anxiety
Time Frame: Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
Generalized Anxiety Disorder Assessment 7 (GAD-7) is a brief 7-item self-report measure for generalized anxiety symptoms. Although developed for measuring severity of generalized anxiety disorder, the GAD-7 measures severity of general anxiety symptoms common to several anxiety disorders
Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
Depression
Time Frame: Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
Patient Health Questionnaire, (PHQ-9) is a 9-item self-report questionnaire measuring level of depressive symptoms. Items are scored on a scale from 0 (not at all) to 3 (nearly every day).
Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, minimum six months follow up
Insomnia
Time Frame: Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, six months follow up
The Bergen Insomnia Scale (BIS) will be used to screen for sleep disturbances. The scale has six items covering different aspects of sleep disturbances the past 4 weeks
Pre-treatment, 1 week post, minimum nine weeks after pre-treatment, six months follow up
Client satisfaction
Time Frame: 1 week post Concentrated Exposure Treatment
Client Satisfaction Questionnaire (CSQ-8) is an eight-item self-report form where patients report their level of satisfaction with the treatment they have undergone.
1 week post Concentrated Exposure Treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Gerd Kvale, PhD, Haukeland UH
  • Study Chair: Gunvor Launes, MD, Sorlandet Hospital HF

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2016

Primary Completion (Actual)

June 1, 2018

Study Completion (Anticipated)

June 1, 2023

Study Registration Dates

First Submitted

August 29, 2016

First Submitted That Met QC Criteria

August 31, 2016

First Posted (Estimate)

September 1, 2016

Study Record Updates

Last Update Posted (Actual)

February 11, 2021

Last Update Submitted That Met QC Criteria

February 10, 2021

Last Verified

February 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2016/794 (REK vest)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obsessive Compulsive Disorder (OCD)

Clinical Trials on Concentrated exposure treatment (cET)

3
Subscribe